Benefits of Fractal Approaches in Solid Dosage Form Development
dc.accessRights | Anonymous | * |
dc.audience | Science | en_US |
dc.contributor.author | Abreu-Villela, Renata | |
dc.contributor.author | Kuentz, Martin | |
dc.date.accessioned | 2020-03-03T08:17:56Z | |
dc.date.available | 2020-03-03T08:17:56Z | |
dc.date.issued | 2019-09-06 | |
dc.description.abstract | Pharmaceutical formulations are complex systems consisting of active pharmaceutical ingredient(s) and a number of excipients selected to provide the intended performance of the product. The understanding of materials' properties and technological processes is a requirement for building quality into pharmaceutical products. Such understanding is gained mostly from empirical correlations of material and process factors with quality attributes of the final product. However, it seems also important to gain knowledge based on mechanistic considerations. Promising is here to study morphological and/or topological characteristics of particles and their aggregates. These geometric aspects must be taken into account to better understand how product attributes emerge from raw materials, which includes, for example, mechanical tablet properties, disintegration or dissolution behavior. Regulatory agencies worldwide are promoting the use of physical models in pharmaceutics to design quality into a final product. This review deals with pharmaceutical applications of theoretical models, focusing on percolation theory, fractal, and multifractal geometry. The use of these so-called fractal approaches improves the understanding of different aspects in the development of solid dosage forms, for example by identifying critical drug and excipient concentrations, as well as to study effects of heterogeneity on dosage form performance. The aim is to link micro- and macrostructure to the emerging quality attributes of the pharmaceutical solid dosage forms as a strategy to enhance mechanistic understanding and to advance pharmaceutical development and manufacturing processes. | en_US |
dc.description.uri | https://www.ncbi.nlm.nih.gov/pubmed/31493266 | en_US |
dc.identifier.doi | 10.1007/s11095-019-2685-5 | |
dc.identifier.issn | 0724-8741 | |
dc.identifier.issn | 1573-904X | |
dc.identifier.uri | https://irf.fhnw.ch/handle/11654/30640 | |
dc.issue | 11 | en_US |
dc.language.iso | en | en_US |
dc.publisher | Springer | en_US |
dc.relation.ispartof | Pharmaceutical Research | en_US |
dc.subject | fractal geometry | en_US |
dc.subject | fractal-like kinetics | en_US |
dc.subject | geometric distribution | en_US |
dc.subject | percolation theory | en_US |
dc.subject | solid dosage forms | en_US |
dc.title | Benefits of Fractal Approaches in Solid Dosage Form Development | en_US |
dc.type | 01A - Beitrag in wissenschaftlicher Zeitschrift | |
dc.volume | 36 | en_US |
dspace.entity.type | Publication | |
fhnw.InventedHere | Yes | en_US |
fhnw.IsStudentsWork | no | en_US |
fhnw.PublishedSwitzerland | Yes | en_US |
fhnw.ReviewType | Anonymous ex ante peer review of a complete publication | en_US |
fhnw.affiliation.hochschule | Hochschule für Life Sciences FHNW | de_CH |
fhnw.affiliation.institut | Institut für Pharma Technology | de_CH |
fhnw.pagination | 156 | en_US |
fhnw.publicationOnline | Ja | en_US |
fhnw.publicationState | Published | en_US |
relation.isAuthorOfPublication | 68819448-8611-488b-87bc-1b1cf9a6a1b4 | |
relation.isAuthorOfPublication.latestForDiscovery | 68819448-8611-488b-87bc-1b1cf9a6a1b4 |